T102C

Analytical Considerations for Low Dose DAI Studies

Date

September 10, 2020

Speaker

Pfizer, Inc.

Related Products

Thumbnail for Midwest Regional Forum 2020 - Day 2

Midwest Regional Forum 2020 - Day 2

Thumbnail for Panel and Q&A

Thumbnail for Analytical Considerations for Low Dose DAI Studies

Analytical Considerations for Low Dose DAI Studies

Dosage Administration Instructions are required prior to clinical dosing throughout a product lifecycle…